Why the government should pay for treatment with
thrombopoietin drugs. There are very few drugs
used to treat Immune Thrombocytopenia Purpura and
related blood disorders. The newest and most
effective treatments are the new thrombopoietin
drugs such as Romniplastin(NPlate). These drugs
save the lives of persons who are refractory and
have no other options to keep their bodies from
destroying their platelets. If Medicare does not
pay for them, they are essentially stopping the
doctors form prescribing life saving treatment.
Why not let the doctors make the decisions about
what treatment will work best for each patient?
The government should certainly allow this option
for its citizens.

Another issue is that all other treatments are
more expensive than this one treatment. Also
persons with this blood disorder are oftne
hospitalized due to hemorrhaing problems so in
the long run adding this drug to the treatmens
paid for by the government is actually less
costly and a savings.